• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET TETRA 2.5MM X 6.0CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET TETRA 2.5MM X 6.0CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Catalog Number TG5412560
Medical Device Problem Code Migration (4003)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/27/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H3 other text : the device is not available to the manufacturer.
 
Event or Problem Description
It was reported that during a ruptured anterior communicating artery aneurysm balloon assisted coiling procedure, the subject coil appeared to be stable during initial coiling and on final angiogram following the treatment.Physician performed a computed tomography hours after treatment and subject coil tail was found protruding from the aneurysm into the a1.A second balloon assisted coil procedure was done to secure the aneurysm.The patient is in critical condition due to pulmonary issues.
 
Additional Manufacturer Narrative
Due to the automated manufacturing execution system (mes), there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device is not available; therefore, functional testing as well as visual testing cannot be performed.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.The physician reported that significant amount of coil tail protrudes from the aneurysm (after completion of the procedure).There were no reported issues during delivery, placement or detachment and there is no allegation of a device malfunction.While there are a number of potential causes for the reported issue, because review and analysis of available information failed to identify a definitive cause and the device was not returned, an assignable cause of "undeterminable" was assigned to as reported "main coil protrusion".
 
Event or Problem Description
It was reported that during a ruptured anterior communicating artery aneurysm balloon assisted coiling procedure, the subject coil appeared to be stable during initial coiling and on final angiogram following the treatment.Physician performed a computed tomography hours after treatment and subject coil tail was found protruding from the aneurysm into the a1.A second balloon assisted coil procedure was done to secure the aneurysm.The patient is in critical condition due to pulmonary issues.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET TETRA 2.5MM X 6.0CM
Common Device Name
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key19140214
Report Number3008881809-2024-00174
Device Sequence Number18501296
Product Code HCG
UDI-Device Identifier07613327578638
UDI-Public07613327578638
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K222533
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberTG5412560
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 03/29/2024
Supplement Date Received by Manufacturer05/31/2024
Initial Report FDA Received Date04/18/2024
Supplement Report FDA Received Date06/20/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
TRANSFORM SUPER COMPLIANT (STRYKER).
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-